Chris joined LifeArc as Investment Principal at LifeArc Ventures in 2021. He is responsible for new investments and managing existing portfolio companies.
Chris has held key business development roles in the investment and charity research industries, sourcing, assessing and converting life science opportunities. Previously, he was an Associate at the trans-Atlantic venture investor Advent Life Sciences, leading the diligence on a range of therapeutic and medical device opportunities, and supporting the growth of several portfolio companies.
Chris worked for 10 years in the university technology transfer sector with UCL Business and Cancer Research Technology. He successfully supported and commercialised a number of oncology and gene and cell therapy opportunities, and in addition, he was involved in executing a number of strategic initiatives such as the CRUK Stratified Medicine Programme and Grand Challenge awards.
Chris received his M.Biochem from the University of Oxford and a PhD in Genetics from the University of Cambridge in the lab of Prof. Fiona Watt.
